Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
KE ›
KEVLIPAR
Trademark search for:
KEVLIPAR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-01-09 — Application filed
2020-01-13 — Application filed
2020-01-14 — Application filed
2020-01-27 — Final disposition recorded
2020-01-27 — Final disposition recorded
2020-01-27 — Assigned to examiner
2020-01-27 — Final disposition recorded
2020-02-11 — Teas/email correspondence entered
2020-02-11 — Office action issued
2020-02-11 — Correspondence received in law office
2020-02-12 — Approved for pub - principal register
2020-02-24 — Assigned to lie
2020-02-25 — Law office publication review completed
2020-03-11 — Notification of notice of publication e-mailed
2020-03-31 — Published for opposition
2020-03-31 — Official gazette publication confirmation e-mailed
2020-05-26 — Noa e-mailed - sou required from applicant
2020-11-20 — Sou teas extension received
2020-11-20 — Sou extension 1 filed
2020-11-20 — Sou extension 1 granted
2020-11-24 — Notice of approval of extension request e-mailed
2021-05-20 — Sou teas extension received
2021-05-20 — Sou extension 2 filed
2021-05-20 — Sou extension 2 granted
2021-05-22 — Notice of approval of extension request e-mailed
2021-11-22 — Sou teas extension received
2021-11-22 — Sou extension 3 filed
2021-11-22 — Sou extension 3 granted
2021-11-24 — Notice of approval of extension request e-mailed
2022-05-01 — Sou teas extension received
2022-05-01 — Sou extension 4 granted
2022-05-01 — Sou extension 4 filed
2022-05-03 — Notice of approval of extension request e-mailed
2022-11-21 — Sou teas extension received
2022-11-21 — Sou extension 5 filed
2022-12-02 — Case assigned to intent to use paralegal
2022-12-02 — Sou extension 5 granted
2022-12-03 — Notice of approval of extension request e-mailed
2023-06-26 — Application abandoned
2023-06-26 — Application abandoned
2023-06-26 — Final status recorded
Owner Information
AbbVie Inc.
North Chicago , IL
AbbVie Inc.
North Chicago , IL
Correspondent
Cheryl A. Withycombe AbbVie Inc. 18655 Teller Avenue Mail code: AND-250C Irvine, CA 92612
Filing Details
Filing Date:
2020-01-09
Status Date:
2023-06-26
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.